Delirium	delirium	O	S_disease
during	during	O	O
clozapine	clozapine	S_chemical	O
treatment	treatment	O	O
:	:	O	O
incidence	incidence	O	O
and	and	O	O
associated	associated	O	O
risk	risk	O	O
factors	factors	O	O
.	.	O	O

BACKGROUND	background	O	O
:	:	O	O
Incidence	incidence	O	O
and	and	O	O
risk	risk	O	O
factors	factors	O	O
for	for	O	O
delirium	delirium	O	S_disease
during	during	O	O
clozapine	clozapine	S_chemical	O
treatment	treatment	O	O
require	require	O	O
further	further	O	O
clarification	clarification	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
We	we	O	O
used	used	O	O
computerized	computerized	O	O
pharmacy	pharmacy	O	O
records	records	O	O
to	to	O	O
identify	identify	O	O
all	all	O	O
adult	adult	O	O
psychiatric	psychiatric	O	S_disease
inpatients	inpatients	O	O
treated	treated	O	O
with	with	O	O
clozapine	clozapine	S_chemical	O
(	(	O	O
1995	1995	O	O
-	-	O	O
96	96	O	O
)	)	O	O
,	,	O	O
reviewed	reviewed	O	O
their	their	O	O
medical	medical	O	O
records	records	O	O
to	to	O	O
score	score	O	O
incidence	incidence	O	O
and	and	O	O
severity	severity	O	O
of	of	O	O
delirium	delirium	O	S_disease
,	,	O	O
and	and	O	O
tested	tested	O	O
associations	associations	O	O
with	with	O	O
potential	potential	O	O
risk	risk	O	O
factors	factors	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
Subjects	subjects	O	O
(	(	O	O
n	n	O	O
=	=	O	O
139	139	O	O
)	)	O	O
were	were	O	O
72	72	O	O
women	women	O	O
and	and	O	O
67	67	O	O
men	men	O	O
,	,	O	O
aged	aged	O	O
40.8	40.8	O	O
+	+	O	O
/-	/-	O	O
12.1	12.1	O	O
years	years	O	O
,	,	O	O
hospitalized	hospitalized	O	O
for	for	O	O
24.9	24.9	O	O
+	+	O	O
/-	/-	O	O
23.3	23.3	O	O
days	days	O	O
,	,	O	O
and	and	O	O
given	given	O	O
clozapine	clozapine	S_chemical	O
,	,	O	O
gradually	gradually	O	O
increased	increased	O	O
to	to	O	O
an	an	O	O
average	average	O	O
daily	daily	O	O
dose	dose	O	O
of	of	O	O
282	282	O	O
+	+	O	O
/-	/-	O	O
203	203	O	O
mg	mg	O	O
(	(	O	O
3.45	3.45	O	O
+	+	O	O
/-	/-	O	O
2.45	2.45	O	O
mg/kg	mg/kg	O	O
)	)	O	O
for	for	O	O
18.9	18.9	O	O
+	+	O	O
/-	/-	O	O
16.4	16.4	O	O
days	days	O	O
.	.	O	O

Delirium	delirium	O	S_disease
was	was	O	O
diagnosed	diagnosed	O	O
in	in	O	O
14	14	O	O
(	(	O	O
10.1	10.1	O	O
%	%	O	O
incidence	incidence	O	O
,	,	O	O
or	or	O	O
1.48	1.48	O	O
cases/person-years	cases/person-years	O	O
of	of	O	O
exposure	exposure	O	O
)	)	O	O
;	;	O	O
71.4	71.4	O	O
%	%	O	O
of	of	O	O
cases	cases	O	O
were	were	O	O
moderate	moderate	O	O
or	or	O	O
severe	severe	O	O
.	.	O	O

Associated	associated	O	O
factors	factors	O	O
were	were	O	O
co-treatment	co-treatment	O	O
with	with	O	O
other	other	O	O
centrally	centrally	O	O
antimuscarinic	antimuscarinic	O	O
agents	agents	O	O
,	,	O	O
poor	poor	O	O
clinical	clinical	O	O
outcome	outcome	O	O
,	,	O	O
older	older	O	O
age	age	O	O
,	,	O	O
and	and	O	O
longer	longer	O	O
hospitalization	hospitalization	O	O
(	(	O	O
by	by	O	O
17.5	17.5	O	O
days	days	O	O
,	,	O	O
increasing	increasing	O	O
cost	cost	O	O
)	)	O	O
;	;	O	O
sex	sex	O	O
,	,	O	O
diagnosis	diagnosis	O	O
or	or	O	O
medical	medical	O	O
co-morbidity	co-morbidity	O	O
,	,	O	O
and	and	O	O
daily	daily	O	O
clozapine	clozapine	S_chemical	O
dose	dose	O	O
,	,	O	O
which	which	O	O
fell	fell	O	O
with	with	O	O
age	age	O	O
,	,	O	O
were	were	O	O
unrelated	unrelated	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
Delirium	delirium	O	S_disease
was	was	O	O
found	found	O	O
in	in	O	O
10	10	O	O
%	%	O	O
of	of	O	O
clozapine-treated	clozapine-treated	O	O
inpatients	inpatients	O	O
,	,	O	O
particularly	particularly	O	O
in	in	O	O
older	older	O	O
patients	patients	O	O
exposed	exposed	O	O
to	to	O	O
other	other	O	O
central	central	O	O
anticholinergics	anticholinergics	O	O
.	.	O	O

Delirium	delirium	O	S_disease
was	was	O	O
inconsistently	inconsistently	O	O
recognized	recognized	O	O
clinically	clinically	O	O
in	in	O	O
milder	milder	O	O
cases	cases	O	O
and	and	O	O
was	was	O	O
associated	associated	O	O
with	with	O	O
increased	increased	O	O
length-of-stay	length-of-stay	O	O
and	and	O	O
higher	higher	O	O
costs	costs	O	O
,	,	O	O
and	and	O	O
inferior	inferior	O	O
clinical	clinical	O	O
outcome	outcome	O	O
.	.	O	O

